As real-world evidence (RWE) becomes more integral to healthcare decision-making, challenges around quality standards, regulatory alignment, and cross-border data integration continue to limit its full potential. Despite a growing infrastructure to support RWE, questions remain concerning data quality standards, regulatory alignment, and secure data integration across borders.
In an article published in HIT Consultant, Natalie Schibell (VP, Market Strategy and Communications) explores the evolving RWE landscape in 2025, highlighting the lack of harmonized regulatory definitions, the promise of European initiatives like EMANS 2028, and the lasting impact of the COVID-19 response on evidence generation.Find the full article here to learn more about how meaningfully integrating RWE is essential for delivering real-world impact in healthcare.